Huang S - Search Results

1

Co-Administration with Voriconazole Doubles the Exposure of Ruxolitinib in Patients with Hematological Malignancies.

Zhao Y, Chen P, Dou L, Li F, Li M, Xu L, Chen J, Jia M, Huang S, Wang N, Luan S, Yang J, Bai N, Liu D. Zhao Y, et al. Among authors: huang s. Drug Des Devel Ther. 2022 Mar 25;16:817-825. doi: 10.2147/DDDT.S354270. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35370398 Free PMC article. Clinical Trial.

2

AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.

Fu L, Huang W, Jing Y, Jiang M, Zhao Y, Shi J, Huang S, Xue X, Zhang Q, Tang J, Dou L, Wang L, Nervi C, Li Y, Yu L. Fu L, et al. Among authors: huang s, huang w. FEBS J. 2014 Feb;281(4):1123-31. doi: 10.1111/febs.12673. Epub 2014 Jan 10. FEBS J. 2014. PMID: 24314118 Free article.

3

[Prognostic significance of detecting MLL-AF9 fusion gene expression in patients with acute myeloid leukemia by real-time fluorescence quantitative PCR].

Huang S, Yang H, Gao L, Dou LP, Xu YY, Wang N, Wang LL, Yu L. Huang S, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Dec;21(6):1435-40. doi: 10.7534/j.issn.1009-2137.2013.06.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24370025 Chinese.

4

[A Retrospective Study of Ph Negative Adolescent and Young Adults with Acute B Lymphoblastic Leukemia in Two Centers].

Gao HH, Jing Y, Liu MJ, Li HH, Huang WR, Gao CJ, Liu DH, Li YH, Huang S, Li Y, Liu J, Zhang YQ, Yu L. Gao HH, et al. Among authors: huang wr, huang s. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Dec;24(6):1683-1690. doi: 10.7534/j.issn.1009-2137.2016.06.013. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016. PMID: 28024477 Chinese.

5

Loss of the Y chromosome predicts a high relapse risk in younger adult male patients with t(8;21) acute myeloid leukemia on high-dose cytarabine consolidation therapy: a retrospective multicenter study.

Zhou W, Chen G, Gong D, Li Y, Huang S, Wang N, Xu Q, Xiong Q, Jing Y, Lv N, Wang L, Li Y, Yu L. Zhou W, et al. Among authors: huang s. Leuk Lymphoma. 2020 Apr;61(4):820-830. doi: 10.1080/10428194.2019.1683734. Epub 2019 Nov 14. Leuk Lymphoma. 2020. PMID: 31724463

6

Loss of X chromosome predicts favorable prognosis in female patients with t(8;21) acute myeloid leukemia.

Chen G, Zhou W, Gong D, Li Y, Huang S, Wang N, Xu Q, Xiong Q, Jing Y, Lv N, Wang L, Li Y, Yu L. Chen G, et al. Among authors: huang s. Leuk Lymphoma. 2020 May;61(5):1168-1177. doi: 10.1080/10428194.2019.1709836. Epub 2020 Jan 9. Leuk Lymphoma. 2020. PMID: 31916883

7

High Risk of Recurrence of Malignancy Noted in Four-day rATG Regimen After Allogeneic PBSCT From Matched Sibling Donors.

Wang N, Wang H, Fang S, Du J, Huang S, Li F, Jin X, Jia M, Xu L, Dou L, Liu D. Wang N, et al. Among authors: huang s. Transplant Cell Ther. 2022 Nov;28(11):769.e1-769.e9. doi: 10.1016/j.jtct.2022.08.012. Epub 2022 Aug 13. Transplant Cell Ther. 2022. PMID: 35973670 Free article.

8

Next-generation sequencing revealed factors associated with cumulative incidence of relapse and leukemia-free survival in patients with newly diagnosed acute myeloid leukemia.

Huang S, Chen P, Wang L, Xu L, Jia M, Chen J, Wang N, Li F, Liu L, Qin J, Wang C, Cao S, Dou L, Liu D. Huang S, et al. Cancer Pathog Ther. 2022 Sep 27;1(1):25-32. doi: 10.1016/j.cpt.2022.09.003. eCollection 2023 Jan. Cancer Pathog Ther. 2022. PMID: 38328603 Free PMC article.

9

[Venetoclax Combined with CACAG Regimen in the Treatment of Patients with Refractory/Relapse Acute Myeloid Leukemia: A Prospective Clinical Study].

Gao WJ, Yang JJ, Li M, Wen YN, Jiao YF, LE N, Liu YC, Wang N, Huang S, Dou LP. Gao WJ, et al. Among authors: huang s. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Feb;32(1):90-95. doi: 10.19746/j.cnki.issn.1009-2137.2024.01.015. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38387905 Chinese.

10

Next-generation sequencing reveals relapse and leukemia-free survival risks in newly diagnosed acute myeloid leukemia treated with CAG regimen combined with decitabine.

Huang S, Chen P, Wang L, Xu L, Wang N, Li F, Dou L, Liu D. Huang S, et al. Cancer Pathog Ther. 2023 Oct 12;2(2):112-120. doi: 10.1016/j.cpt.2023.10.002. eCollection 2024 Apr. Cancer Pathog Ther. 2023. PMID: 38601484 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,028 results

Search Page